New Insights into Potential Therapeutic Targets for Neuroendocrine Prostate Cancer: From Bench to Clinic
1Department of Urology, The Fifth Affiliated Hospital, Southern Medical University, Guangzhou 510630, Guangdong, PR China.
2Department of Urology, Fudan University Shanghai Cancer Center, Shanghai 200032, PR China.
3Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, PR China.
4Shanghai Genitourinary Cancer Institute, Shanghai 200032, PR China.
5Shantou University Medical College, Shantou 515041, Guangdong, PR China.
6Department of Oncology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong, PR China.
7Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, PR China.
8Department of Radiation and Medical Oncology, Hubei Cancer Clinical Study Center & Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital of Wuhan University, Wuhan 430072, China.
9Department of Radiotherapy, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou 510095, Guangdong, PR China.
10Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John’s University, Queens, New York, NY 11439, USA.
11Department of Urology, The Third Affiliated Hospital, Southern Medical University, Guangzhou 510630, Guangdong, PR China.
收起